Second Affiliated Hospital, School Of Medicine, Zhejiang University
Clinical trials sponsored by Second Affiliated Hospital, School Of Medicine, Zhejiang University, explained in plain language.
-
New drug combo trial aims to fight advanced bowel cancer
Disease control OngoingThis study is testing if adding a new immunotherapy drug called sintilimab to standard chemotherapy works better for people with advanced colorectal cancer that has spread and has a specific genetic change (RAS mutation). It will involve about 446 adults who have not yet received…
Phase: PHASE3 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 04, 2026 02:35 UTC
-
Smart pump tech aims to make eye surgery safer
Disease control OngoingThis study is testing a new 'adaptive fluidics' system designed to make lens surgery (like cataract removal) safer. The system aims to keep the pressure inside the eye stable during the operation, which can reduce risks. Researchers are comparing this new technology to the standa…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Shockwaves vs. heart artery hardening: can a new combo treatment improve survival?
Disease control OngoingThis study is testing if adding a new shockwave therapy to the standard procedure for opening blocked heart arteries works better for patients with moderate-to-severe artery hardening (calcification). Researchers will compare the long-term health of over 1,000 patients who receiv…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Scientists test 'Living Drug' to heal scarred hearts
Disease control OngoingThis early-stage study is testing a new cell therapy for people with severe, end-stage heart failure from dilated cardiomyopathy. Researchers are modifying a patient's own immune cells to target and reduce scarring in the heart muscle, with the goal of improving heart function. T…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New capsule tested to stop liver Cancer's return
Disease control OngoingThis study is testing whether Icaritin soft capsules can help prevent liver cancer from returning after surgery in patients at high risk of recurrence. Twenty patients who have had their liver cancer surgically removed will take the capsules and be monitored with regular scans. R…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Doctors question routine antibiotics for liver bleeding prevention
Disease control OngoingThis study aims to determine if antibiotics are necessary during endoscopic procedures to prevent re-bleeding in patients with liver cirrhosis who have previously experienced variceal bleeding. Researchers are comparing outcomes between patients who receive preventive antibiotics…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
Study tests if your own blood can heal shoulder tears better than steroids
Disease control OngoingThis study aims to find the best treatment for different types of shoulder tendon tears after surgical repair. Researchers are comparing three approaches: a steroid injection, an injection of the patient's own concentrated platelets (platelet-rich plasma), and a placebo injection…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
New kidney stone surgery challenges standard treatment
Disease control ENROLLING_BY_INVITATIONThis study compares a newer surgery called VISOR against the standard PCNL procedure for removing medium-sized kidney stones (2-4cm). Researchers want to see which method clears stones better and faster while causing fewer side effects like pain, fever, or injury. About 170 patie…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New combo treatment aims to shrink tumors before lung cancer surgery
Disease control OngoingThis study is testing whether adding an immunotherapy drug called serplulimab to standard chemotherapy before surgery helps people with operable non-small cell lung cancer. The goal is to see if this combination treatment can better shrink tumors before removal, lower the chance …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Custom cancer vaccine fights to keep esophageal cancer at bay
Disease control OngoingThis early-stage study is testing a personalized vaccine designed to train the immune system to attack a patient's specific esophageal cancer. It is for people who have already completed standard treatments including surgery, chemotherapy, and immunotherapy, with the goal of prev…
Phase: PHASE1 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New combo therapy aims to shrink tumors before esophageal cancer surgery
Disease control OngoingThis study is testing whether adding an immunotherapy drug called serplulimab to standard chemotherapy before surgery is safe and effective for people with a type of esophageal cancer that can be removed by surgery. The goal is to see if this combination treatment can better shri…
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC
-
Precision brain surgery trial aims to improve recovery from devastating strokes
Disease control OngoingThis study is comparing two ways to treat a specific type of serious brain bleed (stroke) in the deep brain. It tests whether a precise, minimally invasive surgery to drain the blood clot, followed by clot-busting medicine, leads to better recovery than standard medication alone.…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New combo therapy aims to zap eye cancer with fewer side effects
Disease control OngoingThis study is testing if a new drug, orelabrutinib, works better and is safer when combined with either very low-dose radiation or another drug called rituximab for a rare, slow-growing lymphoma around the eye. It involves 39 adults with early-stage disease who haven't had prior …
Phase: PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Mar 05, 2026 13:59 UTC
-
AI scans your Cancer's future: new study aims to predict lung tumor behavior from images
Diagnosis OngoingThis study aims to use artificial intelligence (AI) to analyze standard PET/CT scan images from 500 past lung cancer patients. The goal is to build computer models that can more accurately determine the cancer's stage and type, predict its genetic profile, and forecast a patient'…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Diagnosis
Last updated Apr 04, 2026 02:21 UTC
-
Zap your migraine away? electrical device trial seeks pain relief
Symptom relief OngoingThis study is testing whether a small electrical stimulation device placed on the skin can help treat migraine attacks. Researchers are comparing the device to a placebo in 206 adults with migraines to see if it reduces headache pain and symptoms like nausea and light sensitivity…
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Symptom relief
Last updated Mar 31, 2026 12:11 UTC